Glasgow Local Peer Support Group
Wednesday 2 October, 11.00am - 1.00pm - In-person meet up at Visibility Scotland with guest speaker Graeme Marden from Sight and Sound Technology.
Search results
Wednesday 2 October, 11.00am - 1.00pm - In-person meet up at Visibility Scotland with guest speaker Graeme Marden from Sight and Sound Technology.
Beacon Therapeutics announced positive results from their phase 2 gene therapy trial for X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene.
Nanoscope Therapeutics has announced positive results from their two year randomised controlled phase 2b optogenetic therapy trial for late-stage retinitis pigmentosa (RP).
Saturday 12 October, 10.30am - 3.30pm - In-person - Come and join the Hampshire group for a visit to the Tudor House and Garden in historic Southampton, followed by a pub lunch.
The collective partnership of eight of the leading charities in the sight loss sector, known for the last three years as the VI Charity Sector Partnership, has re-launched under a new identity of the ‘Vision Partnership’ with a re-invigorated purpose and new strategic focus.
We can provide all the support your organisation needs to work with us; from ideas to practical support and materials. The Retina UK team will help your contribution be as fun and rewarding as possible.
As part of our aim to nurture young scientists, we are very pleased to introduce one of our new PhD students as part of a co-funding agreement with the Macular Society.
Please read our conditions of use carefully as by using the website you will be assumed to have agreed to be bound by them.
Steve is a Paralympian who was diagnosed with retinitis pigmentosa (RP) in 2011.
Saturday 28 September 2024, 5pm - In-person meet up for food and drinks at the Pendulum Hotel Garden Bar & Restaurant following on from our Annual Conference.